Skip to main content
Supriya Lifescience Limited logo

Supriya Lifescience Limited — Investor Relations & Filings

Ticker · SUPRIYA ISIN · INE07RO01027 LEI · 894500RBVJX1EOJP0Y02 BSE.NS Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2022-02-15 Investor Presentation
Country IN India
Listing BSE.NS SUPRIYA

About Supriya Lifescience Limited

https://www.supriyalifescience.com

Supriya Lifescience Limited is a research-driven manufacturer of Active Pharmaceutical Ingredients (APIs) with a focus on diverse therapeutic segments. The company specializes in the production of antihistamines, anti-allergics, vitamins, anesthetics, and anti-asthmatics. Its core product portfolio includes Chlorpheniramine Maleate, Ketamine Hydrochloride, and Salbutamol Sulphate, maintaining a significant global market share in these niche categories. Operating with a strong emphasis on backward integration, the firm ensures supply chain reliability and cost efficiency. The manufacturing infrastructure is compliant with international regulatory standards, including approvals from the USFDA, EDQM, and PMDA. Supriya Lifescience serves a broad international clientele across more than 100 countries, catering to both regulated and semi-regulated markets through its advanced R&D capabilities and commitment to quality excellence.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 95% confidence The document is a letter addressed to stock exchanges informing about a schedule of analyst/institutional investor meetings held via video conference. It references an Investor Presentation that has already been uploaded on the company's website and stock exchanges. The document explicitly states that no unpublished price sensitive information was discussed. The content is an announcement about the meeting and the availability of the presentation, not the presentation itself. The document length is short (2129 characters), and it serves as a notification rather than a detailed report or transcript. Therefore, it fits the category of an Investor Presentation announcement or update. Given the options, the best classification is Investor Presentation (IP).
2022-02-15 English
Updates
Regulatory Filings
2022-02-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a letter addressed to stock exchanges informing them about the schedule of analyst and institutional investor meetings. It mentions that an Investor Presentation has been uploaded on the company's website and stock exchanges. The document is short (2225 characters) and serves as an announcement of the upcoming investor meeting and the availability of the presentation, rather than the presentation itself. Therefore, it is not the investor presentation report but an announcement related to it. According to the classification rules, such announcements about investor meetings and presentations fall under Investor Presentation (IP) if the presentation itself is included, but here only the schedule and notice are provided. Since the document is primarily an announcement of the meeting and the presentation availability, it fits best under Investor Presentation (IP) category as it relates to investor communication and presentation scheduling.
2022-02-01 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings
2022-01-31 English
Monitoring Agency Report
Regulatory Filings
2022-01-27 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 199 characters, which is extremely short and contains no report content. It appears to be a placeholder or an announcement without actual report data. According to the MENU VS MEAL RULE, such a short document with no financial data or detailed content should be classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Given the lack of any specific indication that it is a report publication announcement, the safest classification is Regulatory Filings (RNS) as a fallback category.
2022-01-27 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.